Top

Published in:

01-08-2020 | Antiphospholipid Syndrome | Letter to the Editor

Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia

Authors: Bingwen Eugene Fan, Yew Woon Chia, Christina Lai Lin Sum, Ponnudurai Kuperan, Stephrene Seok Wei Chan, Li Min Ling, Glenn Wei Leong Tan, Serene Si Ning Goh, Lai Har Wong, Shu Ping Lim, Kian Guan Eric Lim, Hwee Tat Tan, Mui Kia Ang, Soon Lee Lau, Kiat Hoe Ong, Jensen Ng

Published in: Journal of Thrombosis and Thrombolysis | Issue 2/2020

Excerpt

To the editor, …

Becker RC (2020) COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis. https://doi.org/10.1007/s11239-020-02134-3 CrossRefPubMedPubMedCentral

Perini P, Nabulsi B, Massoni CB, Azzarone M, Freyrie A (2020) Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19. Lancet. https://doi.org/10.1016/S0140-6736(20)31051-5 CrossRefPubMedPubMedCentral

Lancé MD (2015) A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis. Thromb J 13:1. https://doi.org/10.1186/1477-9560-13-1 CrossRefPubMedPubMedCentral

Harzallah I, Debliquis A, Drénou B (2020) Lupus anticoagulant is frequent in patients with Covid-19. J Thromb Haemost. https://doi.org/10.1111/jth.14867 CrossRefPubMedPubMedCentral

Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W et al (2020) Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. https://doi.org/10.1056/NEJMc2007575 CrossRefPubMedPubMedCentral

Schouwers SM, Delanghe JR, Devreese KM (2010) Lupus anticoagulant (LAC) testing in patients with inflammatory status: does C-reactive protein interfere with LAC test results? Thromb Res 125(1):102–104. https://doi.org/10.1016/j.thromres.2009.09.001 CrossRefPubMed

Connell NT, Battinelli EM, Connors JM (2020) Coagulopathy of COVID-19 and antiphospholipid antibodies. J Thromb Haemost. https://doi.org/10.1111/jth.14893 CrossRefPubMedPubMedCentral

Walsh M, Moore EE, Moore H, Thomas S, Lune SV, Zimmer D et al (2019) Use of viscoelastography in malignancy-associated coagulopathy and thrombosis: a review. Semin Thromb Hemost 45(04):354–372. https://doi.org/10.1055/s-0039-1688497 CrossRefPubMed

Toukh M, Siemens DR, Black A, Robb S, Leveridge M, Graham CH, Othman M (2014) Thromboelastography identifies hypercoagulablilty and predicts thromboembolic complications in patients with prostate cancer. Thromb Res 133(1):88–95CrossRefPubMed

10.

Panigada M, Bottino N, Tagliabue P et al (2020) Hypercoagulability of COVID-19 patients in intensive care unit. A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. https://doi.org/10.1111/jth.14850 CrossRefPubMed

11.

Ruberto MF, Marongiu F, Mandas A, Mameli A, Porru M, Cianchetti E et al (2018) The venous thromboembolic risk and the clot wave analysis: a useful relationship? Clin Chem Lab Med 56:448–453. https://doi.org/10.1515/cclm-2017-0678 CrossRefPubMed

12.

Tan CW, Cheen MHH, Wong WH et al (2019) Elevated activated partial thromboplastin time-based clot waveform analysis markers have strong positive association with acute venous thromboembolism. Biochem Med 29(2):020710

13.

Tan CW, Low JGH, Wong WH, Chua YY, Goh SL, Ng HJ (2020) Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability. Am J Hematol. https://doi.org/10.1002/ajh.25822 CrossRefPubMedPubMedCentral

14.

Wallace NH, Dumont A, Burns A, Christopher TA, Rinder HM, Kriegel MA, Buckley LM, Erkan D, Lee AI (2016) Thromboelastography in the characterization of coagulation status in antiphospholipid syndrome. Blood 128(22):4983. https://doi.org/10.1182/blood.V128.22.4983.4983 CrossRef

15.

Karen AB, Beverley JH (2010) The utility of thromboelastography (TEG) in the management of patients with isolated antiphospholipid antibodies (aPL) or primary antiphospholipid syndrome (PAPS). Blood 116(21):3179. https://doi.org/10.1182/blood.V116.21.3179.3179 CrossRef

Title: Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia
Authors: Bingwen Eugene Fan
Yew Woon Chia
Christina Lai Lin Sum
Ponnudurai Kuperan
Stephrene Seok Wei Chan
Li Min Ling
Glenn Wei Leong Tan
Serene Si Ning Goh
Lai Har Wong
Shu Ping Lim
Kian Guan Eric Lim
Hwee Tat Tan
Mui Kia Ang
Soon Lee Lau
Kiat Hoe Ong
Jensen Ng
Publication date: 01-08-2020
Publisher: Springer US
Keywords: Antiphospholipid Syndrome
COVID-19
Antiphospholipid Syndrome
Thrombosis
Heparin
Published in: Journal of Thrombosis and Thrombolysis / Issue 2/2020
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-020-02165-w

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2020

Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel

Correction to: Heparin resistance in COVID‑19 patients in the intensive care unit

Monitoring the roles of prothrombin activation fragment 1 and 2 (F1 + 2) in patients with atrial fibrillation receiving rivaroxaban and apixaban

Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia

Benefits of short-term or prolonged as compared to standard 1 year DAPT in patients with acute coronary syndrome treated with drug-eluting stents: a meta-analysis of 9 randomized trials

Non-vitamin K antagonist oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation: a systematic review and meta-analysis

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page